BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17146471)

  • 1. Towards a muscarinic hypothesis of schizophrenia.
    Raedler TJ; Bymaster FP; Tandon R; Copolov D; Dean B
    Mol Psychiatry; 2007 Mar; 12(3):232-46. PubMed ID: 17146471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?
    Scarr E; Dean B
    J Neurochem; 2008 Dec; 107(5):1188-95. PubMed ID: 18957051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic aspects of schizophrenia.
    Tandon R
    Br J Psychiatry Suppl; 1999; (37):7-11. PubMed ID: 10211133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotics in the early stage of development.
    Biedermann F; Fleischhacker WW
    Curr Opin Psychiatry; 2009 May; 22(3):326-30. PubMed ID: 19346948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the cholinergic system in the pathology and treatment of schizophrenia.
    Scarr E; Dean B
    Expert Rev Neurother; 2009 Jan; 9(1):73-86. PubMed ID: 19102670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
    Goto Y; Grace AA
    Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia.
    du Bois TM; Deng C; Huang XF
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):878-88. PubMed ID: 16005134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic receptors in psychiatric disorders - can we mimic 'health'?
    Scarr E
    Neurosignals; 2009; 17(4):298-310. PubMed ID: 19816066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia.
    Ohara K
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):469-74. PubMed ID: 17184889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA and schizophrenia: a review of basic science and clinical studies.
    Wassef A; Baker J; Kochan LD
    J Clin Psychopharmacol; 2003 Dec; 23(6):601-40. PubMed ID: 14624191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O; Demily C; Thibaut F
    Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiology of dopamine in schizophrenia.
    Guillin O; Abi-Dargham A; Laruelle M
    Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia.
    Müller-Vahl KR; Emrich HM
    Expert Rev Neurother; 2008 Jul; 8(7):1037-48. PubMed ID: 18590475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental animal models of schizophrenia.
    Lillrank SM; Lipska BK; Weinberger DR
    Clin Neurosci; 1995; 3(2):98-104. PubMed ID: 7583625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia: from developmental deviance to dopamine dysregulation.
    Murray RM; Lappin J; Di Forti M
    Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S129-34. PubMed ID: 18499406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of muscarinic receptors in psychiatric disorders: a focus on schizophrenia and mood disorders.
    Dean B; Scarr E
    Curr Mol Med; 2015; 15(3):253-64. PubMed ID: 25817858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptors in schizophrenia: is there a role for synaptic plasticity?
    Raedler TJ
    Int Rev Neurobiol; 2004; 59():93-109. PubMed ID: 15006486
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction between N-methyl-D-aspartic acid receptors and D1 dopamine receptors: an important mechanism for brain plasticity.
    Scott L; Aperia A
    Neuroscience; 2009 Jan; 158(1):62-6. PubMed ID: 19000746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.